Diseases, Conditions, Syndromes

On-demand inhalation effective in bronchiolitis

(HealthDay)—In infants with acute bronchiolitis, on-demand inhalation of either adrenaline or saline are effective in shortening hospital stays and reducing the need for supportive treatment, compared with fixed-schedule ...

Medications

FDA approves once-a-day inhaler from Glaxo

The Food and Drug Administration says it has approved a new once-a-day inhaler drug from GlaxoSmithKline for patients with chronic lung disease.

Medications

US panel backs inhaler drug for lung disease

A panel of U.S. respiratory experts voted Wednesday in favor of approving an experimental inhaler drug from GlaxoSmithKline and Theravance for treating chronic lung disease.

Health

Italy bans minors from buying electronic cigarettes

Italy on Tuesday announced plans to raise the legal limit for buying electronic cigarettes to 18 years from a previous 16, citing the high dose of nicotine inhaled when using the smokeless product.

Medications

Inhaler approved for cystic fibrosis patients

(HealthDay)—The TOBI Podhaler (tobramycin inhalation powder) has been approved by the U.S. Food and Drug Administration to treat cystic fibrosis patients infected with Pseudomonas aeruginosa, a bacterium that can damage ...

Diseases, Conditions, Syndromes

Single combo inhaler beats standard rx in asthma

(HealthDay)—Maintenance and reliever therapy with a single inhaled corticosteroid plus a rapid-onset, long-acting, β2 agonist (formoterol) seems beneficial for patients with asthma, according to two studies published in ...

Health

Should caffeine be a regulated substance?

Caffeine-related toxicity, deaths, and near-deaths are an undeniable fact. In Sweden, for example, four people died as a result of confirmed caffeine-related causes in one year. Yet caffeine use continues to grow, including ...

page 13 from 22